Understanding the complexities of treating patients with Myelodysplastic Syndrome

About the episode

Treating patients with Myelodysplastic Syndrome (MDS) is incredibly complicated and even just identifying these patients is challenging. 
Dr. Garcia-Manero joins Molly Scannell Bryan to share his experience in managing patients with MDS, the important nuances in treating patients with this diagnosis, and the role real-world data can play in improving care.

Skip ahead

[2:32] Diagnosis journey for a patient with myelodysplastic syndrome (MDS)
[6:23] Using real-world data to accelerate decision-making
[8:31] Potential of using real-world data as a clinical trial control arm
[10:33] The future of integrating biomarker data into clinical care
[13:48] Changing treatment landscape of MDS
[18:25] Opportunities and challenges in creating real-world evidence to understand treatment and prognosis
[21:33] Gaps in understanding quality of life for patients with MDS
[23:36] MDS progression and the complexities of treatment
[24:56] The need to adapt clinical trials to patients, not the patients to the trials